12.06
Schlusskurs vom Vortag:
$12.49
Offen:
$12.52
24-Stunden-Volumen:
2.78M
Relative Volume:
0.88
Marktkapitalisierung:
$1.38B
Einnahmen:
$631.73M
Nettoeinkommen (Verlust:
$-239.78M
KGV:
-5.9703
EPS:
-2.02
Netto-Cashflow:
$-33.45M
1W Leistung:
-6.22%
1M Leistung:
-15.66%
6M Leistung:
+16.07%
1J Leistung:
-47.50%
10 X Genomics Inc Stock (TXG) Company Profile
Firmenname
10 X Genomics Inc
Sektor
Branche
Telefon
(925) 401-7300
Adresse
6230 STONERIDGE MALL ROAD, PLEASANTON, CA
Vergleichen Sie TXG mit anderen Aktien
Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
---|---|---|---|---|---|---|
![]()
TXG
10 X Genomics Inc
|
12.06 | 1.55B | 631.73M | -239.78M | -33.45M | -2.02 |
![]()
VEEV
Veeva Systems Inc
|
277.94 | 45.70B | 2.97B | 809.93M | 1.33B | 4.87 |
![]()
TEM
Tempus Ai Inc
|
79.23 | 14.62B | 803.32M | -709.10M | -212.68M | -7.8003 |
![]()
DOCS
Doximity Inc
|
74.27 | 13.84B | 550.17M | 201.35M | 232.07M | 1.00 |
![]()
HQY
Healthequity Inc
|
94.26 | 8.09B | 1.15B | 96.70M | -161.99M | 1.09 |
![]()
WAY
Waystar Holding Corp
|
37.04 | 6.58B | 906.14M | -52.62M | 89.62M | -0.3621 |
10 X Genomics Inc Stock (TXG) Upgrades & Downgrades
Datum | Aktion | Analytiker | Ratingänderung |
---|---|---|---|
2025-09-11 | Eingeleitet | Piper Sandler | Neutral |
2025-02-13 | Herabstufung | Leerink Partners | Outperform → Market Perform |
2024-09-03 | Eingeleitet | Leerink Partners | Outperform |
2024-07-22 | Hochstufung | Jefferies | Hold → Buy |
2024-07-18 | Herabstufung | JP Morgan | Overweight → Neutral |
2024-07-10 | Herabstufung | Deutsche Bank | Buy → Hold |
2024-06-27 | Herabstufung | Wolfe Research | Outperform → Peer Perform |
2024-06-25 | Herabstufung | Guggenheim | Buy → Neutral |
2024-06-03 | Fortgesetzt | Jefferies | Hold |
2024-05-01 | Herabstufung | TD Cowen | Buy → Hold |
2023-12-14 | Eingeleitet | Guggenheim | Buy |
2023-12-13 | Eingeleitet | Wolfe Research | Outperform |
2023-12-12 | Hochstufung | BofA Securities | Underperform → Neutral |
2023-07-05 | Fortgesetzt | JP Morgan | Overweight |
2023-05-10 | Eingeleitet | Barclays | Overweight |
2023-03-31 | Eingeleitet | Stephens | Overweight |
2023-02-02 | Eingeleitet | UBS | Neutral |
2022-12-14 | Eingeleitet | Deutsche Bank | Buy |
2022-08-18 | Herabstufung | Goldman | Neutral → Sell |
2022-07-25 | Eingeleitet | Canaccord Genuity | Buy |
2022-07-15 | Herabstufung | BofA Securities | Neutral → Underperform |
2022-07-15 | Herabstufung | William Blair | Outperform → Mkt Perform |
2021-10-15 | Fortgesetzt | Cowen | Outperform |
2021-09-14 | Herabstufung | BofA Securities | Buy → Neutral |
2021-03-15 | Eingeleitet | William Blair | Outperform |
2020-12-02 | Eingeleitet | Goldman | Neutral |
2020-09-09 | Eingeleitet | Morgan Stanley | Overweight |
2020-07-10 | Eingeleitet | Stifel | Buy |
2020-03-05 | Eingeleitet | Guggenheim | Buy |
2020-01-07 | Eingeleitet | Citigroup | Buy |
2019-10-07 | Eingeleitet | BofA/Merrill | Buy |
2019-10-07 | Eingeleitet | Cowen | Outperform |
2019-10-07 | Eingeleitet | JP Morgan | Overweight |
2019-09-24 | Eingeleitet | Evercore ISI | Outperform |
Alle ansehen
10 X Genomics Inc Aktie (TXG) Neueste Nachrichten
10x Genomics (TXG): Is the Market Overlooking the Company's True Value? - simplywall.st
78,249 Shares in 10x Genomics $TXG Purchased by Counterpoint Mutual Funds LLC - MarketBeat
10x Genomics $TXG Shares Sold by Assenagon Asset Management S.A. - MarketBeat
Pallas Capital Advisors LLC Purchases 32,996 Shares of 10x Genomics $TXG - MarketBeat
Goldman Sachs Group Inc. Has $5.63 Million Holdings in 10x Genomics $TXG - MarketBeat
10x Genomics (NASDAQ:TXG) Receives Sell (E+) Rating from Weiss Ratings - MarketBeat
Risk Hedge: Does 10x Genomics Inc. offer margin of safety2025 Earnings Impact & Growth Focused Investment Plans - خودرو بانک
Kera Capital Partners Inc. Buys Shares of 31,018 10x Genomics $TXG - MarketBeat
Acadian Asset Management LLC Acquires 254,607 Shares of 10x Genomics $TXG - MarketBeat
Investment Report: Does Future FinTech Group Inc have consistent dividend growthJuly 2025 Outlook & Precise Swing Trade Entry Alerts - khodrobank.com
Insider Trends: Is 10x Genomics Inc. stock a good pick for beginners2025 Key Lessons & Risk Controlled Swing Alerts - خودرو بانک
Layoff Watch: Can 10x Genomics Inc stock outperform in a bear market2025 Market Overview & Comprehensive Market Scan Reports - خودرو بانک
Breakouts Watch: Can 10x Genomics Inc. sustain earnings growth2025 Price Momentum & Verified High Yield Trade Plans - خودرو بانک
Can 10x Genomics Inc be the next market leader2025 Momentum Check & Free High Return Stock Watch Alerts - khodrobank.com
Risks Report: Will 10x Genomics Inc outperform its industry peersOil Prices & Smart Investment Allocation Tips - خودرو بانک
UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC Purchases 4,987,195 Shares of 10x Genomics $TXG - MarketBeat
Institution Moves: Can 10x Genomics Inc withstand a market correction2025 Historical Comparison & Stepwise Trade Execution Plans - خودرو بانک
Short Squeeze: Will 10x Genomics Inc. benefit from rising consumer demandJuly 2025 Levels & AI Powered Market Trend Analysis - khodrobank.com
Targets Report: What is the long term forecast for Malibu Boats Inc. stockPortfolio Return Summary & Advanced Technical Analysis Signals - khodrobank.com
Aug Momentum: Can 10x Genomics Inc outperform in the next rallyMarket Risk Report & Capital Efficiency Focused Strategies - خودرو بانک
10x Genomics (NASDAQ:TXG) Downgraded to Hold Rating by Wall Street Zen - MarketBeat
New Highs: Is 10x Genomics Inc in a long term uptrend2025 Technical Patterns & Growth Focused Entry Reports - خودرو بانک
Breakout Zone: Is 10x Genomics Inc in a long term uptrendDollar Strength & Real-Time Stock Price Movement Reports - خودرو بانک
Amundi Has $2.55 Million Position in 10x Genomics $TXG - MarketBeat
Aug Spikes: What analysts say about Rani Therapeutics Holdings Inc. stockWeekly Trade Report & Intraday High Probability Alerts - خودرو بانک
Is 10x Genomics Inc. stock influenced by commodity pricesJuly 2025 Decliners & Expert Verified Movement Alerts - خودرو بانک
AQR Capital Management LLC Acquires 695,227 Shares of 10x Genomics $TXG - MarketBeat
Rally Mode: Can 10x Genomics Inc sustain its profitability2025 Top Decliners & Weekly Setup with High ROI Potential - خودرو بانک
10x Genomics (NASDAQ:TXG) Earns Neutral Rating from Analysts at Piper Sandler - MarketBeat
Aug Fed Impact: Is United Fire Group Inc. forming bullish engulfing patternsGold Moves & Fast Moving Trade Plans - خودرو بانک
Buy Signal: Can 10x Genomics Inc sustain earnings growthJuly 2025 WrapUp & Expert-Curated Trade Recommendations - خودرو بانک
Buyback Watch: Is 10x Genomics Inc still a buy after recent gainsJuly 2025 Intraday Action & Low Drawdown Trading Strategies - خودرو بانک
10x Genomics: Surprise Profitability May Be Temporary, But It's Still A Welcome Sign - Seeking Alpha
Travel Stocks: What dividend growth rate does NOMD offerJuly 2025 Closing Moves & Verified Short-Term Plans - خودرو بانک
Market Fear: Is 10x Genomics Inc stock a good pick for beginnersJuly 2025 Reactions & Free Fast Entry Momentum Trade Alerts - خودرو بانک
Weekly Recap: Can 10x Genomics Inc withstand a market correctionDip Buying & High Conviction Trade Alerts - خودرو بانک
Risk On: Can 10x Genomics Inc deliver consistent dividendsQuarterly Profit Review & Verified Short-Term Plans - خودرو بانک
Aug PostEarnings: Can 10x Genomics Inc sustain its profitabilityDay Trade & Real-Time Market Sentiment Alerts - خودرو بانک
Aug Movers: Can 10x Genomics Inc sustain its profitabilityJuly 2025 Review & Fast Gain Stock Trading Tips - خودرو بانک
Trading Recap: How much upside does 10x Genomics Inc. haveWeekly Gains Report & Safe Entry Zone Identification - khodrobank.com
Valuation Update: Can 10x Genomics Inc. be the next market leader2025 Earnings Impact & Fast Gain Stock Tips - خودرو بانک
Voleon Capital Management LP Acquires 82,857 Shares of 10x Genomics $TXG - MarketBeat
Millennium Management LLC Has $46.95 Million Stock Holdings in 10x Genomics $TXG - MarketBeat
Caxton Associates LLP Purchases New Position in 10x Genomics $TXG - MarketBeat
Jacobs Levy Equity Management Inc. Increases Stock Position in 10x Genomics $TXG - MarketBeat
10x Genomics (NASDAQ:TXG) Cut to “Hold” at Wall Street Zen - Defense World
Can trapped investors hope for a rebound in 10x Genomics Inc.2025 Year in Review & Long-Term Capital Growth Ideas - Newser
10x Genomics (TXG) Stock Trades Down, Here Is Why - FinancialContent
10x Genomics $TXG Shares Purchased by Amundi - Defense World
10x Genomics (NASDAQ:TXG) Now Covered by Analysts at Piper Sandler - Defense World
10x Genomics (TXG) Stock Is Up, What You Need To Know - Yahoo Finance
Finanzdaten der 10 X Genomics Inc-Aktie (TXG)
Umsatz
Nettogewinn
Free Cashflow
ENV
10 X Genomics Inc-Aktie (TXG) Insiderhandel
Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
---|---|---|---|---|---|---|---|
Taich Adam | Chief Financial Officer |
Aug 22 '25 |
Sale |
13.79 |
22,315 |
307,657 |
309,273 |
Hindson Benjamin J. | See Remarks |
Aug 22 '25 |
Sale |
13.79 |
7,486 |
103,209 |
440,888 |
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):